Halogenated Aliphatic Toxicity QSARs Employing Metabolite Descriptors

Steven Trohalaki* and Ruth Pachter
Materials & Manufacturing Directorate, Air Force Research Laboratory, Wright-Patterson Air Force Base, Ohio 45433-7702
Kevin T. Geiss and John M. Frazier
Human Effectiveness Directorate, Air Force Research Laboratory, Wright-Patterson Air Force Base, Ohio 45433
J. Chem. Inf. Comput. Sci., 2004, 44 (3), pp 1186–1192
DOI: 10.1021/ci0342627
Publication Date (Web): March 2, 2004
Copyright © 2004 American Chemical Society
*

 Corresponding author phone:  (937)255-6671-x3118; fax:  (937)255-3377; e-mail:  steven.trohalaki@wpafb.af.mil. Corresponding author address:  AFRL/MLPJ Building 651, 3005 Hobson Way, Suite 1, Wright-Patterson Air Force Base, OH 45433-7702.

Abstract

The toxic effects from exposure to halogenated hydrocarbons (HAs), which are produced in large amounts and used in a variety of applications, are well-known. Previously, QSARs for the toxicity of a series of HAs in vitro have been studied extensively. In this work, using a composite toxicity metric calculated from a set of five in vitro hepatotoxicity endpoints determined for 20 HAs, we find that QSARs derived using quantum descriptors calculated from the neutral HA species are statistically similar to QSARs calculated from HA metabolites. In most cases, QSARs derived using descriptors calculated from both neutral HAs and metabolites are statistically superior to those derived using either neutral-HA descriptors or metabolite descriptors. However, to properly utilize metabolite descriptors, multiple QSARs, each of which utilizes a set of HAs that form unique metabolites, must be derived and toxicity values calculated therefrom must be averaged. These average toxicity values agree better with experiment than those calculated from the neutral-HA QSARs.

Tools

History

  • Published In Issue May 24, 2004
  • Received November 12, 2003

Recommend & Share

Related Content

Other ACS content by these authors: